Creuna is pharmaceutical giant AstraZeneca's new strategic partner for digital communication. This partnership is entirely new, and Creuna's brief is for the entire Scandinavian market.
AstraZeneca is one of the world's leading pharmaceutical and research companies, employing over 62,000 people worldwide. With a head office in Sweden and local offices in Denmark, Norway, and Finland, AstraZeneca Nordic is responsible for marketing pharmaceuticals in Sweden.
During the spring, AstraZeneca looked for business partners to work on digital communication. Valued qualities included the agency's ability to create business-oriented strategies and solutions with proven business benefits. Along with the ability to optimize digital presence, these represented important criteria for evaluation during the selection process.
Following this comprehensive selection process, Creuna was chosen as Astra Zeneca Nordic's strategic partner. Initially, the task was to develop a web strategy for all therapy areas for the four Scandinavian markets. This included developing new concepts, developing web analysis and optimization, and driving the appropriate traffic to the various websites.
"Becoming AstraZeneca's new strategic partner is truly exciting," says Magnus Palm, VP of Sales at Creuna. "We will take their online presence to the next level, and secure the business benefits that are made possible by digital channels."
The partnership between AstraZeneca and Creuna was launched during May.
For further information, please contact:
Magnus Palm
VP Sales, Creuna Sverige AB
Telephone: +46 733 13 70 56
e-mail: magnus.palm@creuna.se
Thomas Enzell,
CEO, Creuna Sverige AB
Telephone: +46 70 561 46 40
e-mail: thomas.enzell@creuna.se
Carolina von Schantz,
Communication Manager, Creuna Sverige
Telephone: +46 733 13 70 33
e-mail: carolina.von.schantz@creuna.se